Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion‐guided biopsy increase the detection of anteriorly located prostate cancers

To describe the detection rate of anteriorly located prostate cancer (PCa) with the addition of magnetic resonance imaging (MRI)/ultrasonography (US) fusion‐guided biopsy (FGB) to the standard transrectal ultrasonography (TRUS)‐guided biopsy.

[1]  P. Choyke,et al.  Diagnostic value of biparametric magnetic resonance imaging (MRI) as an adjunct to prostate‐specific antigen (PSA)‐based detection of prostate cancer in men without prior biopsies , 2015, BJU international.

[2]  P. Choyke,et al.  Diagnostic value of biparametric MRI as an adjunct to PSA-based detection of prostate cancer. , 2014 .

[3]  Z. Tandoğdu,et al.  Infective complications after prostate biopsy: outcome of the Global Prevalence Study of Infections in Urology (GPIU) 2010 and 2011, a prospective multinational multicentre prostate biopsy study. , 2013, European urology.

[4]  J. Nesland,et al.  Transperineal prostate biopsy detects significant cancer in patients with elevated prostate‐specific antigen (PSA) levels and previous negative transrectal biopsies , 2012, BJU international.

[5]  S. Madersbacher,et al.  Re: Thomas Hambrock, Caroline Hoeks, Christina Hulsbergen-van de Kaa, et al. Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. Eur Urol 2012;61:17 , 2012, European urology.

[6]  Y. Ishikawa,et al.  Characteristics and clinical significance of prostate cancers missed by initial transrectal 12‐core biopsy , 2012, BJU international.

[7]  S Larry Goldenberg,et al.  Underestimation of Gleason score at prostate biopsy reflects sampling error in lower volume tumours , 2012, BJU international.

[8]  H. Hricak,et al.  Normal central zone of the prostate and central zone involvement by prostate cancer: clinical and MR imaging implications. , 2012, Radiology.

[9]  Georgios Sakas,et al.  A novel stereotactic prostate biopsy system integrating pre-interventional magnetic resonance imaging and live ultrasound fusion. , 2011, The Journal of urology.

[10]  Xavier Leroy,et al.  Combined multiparametric MRI and targeted biopsies improve anterior prostate cancer detection, staging, and grading. , 2011, Urology.

[11]  H Ballentine Carter,et al.  Complications after prostate biopsy: data from SEER-Medicare. , 2011, The Journal of urology.

[12]  Baris Turkbey,et al.  Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.

[13]  Pingkun Yan,et al.  Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. , 2011, The Journal of urology.

[14]  W. Butler,et al.  The incidence of transition zone prostate cancer diagnosed by transperineal template-guided mapping biopsy: implications for treatment planning. , 2011, Urology.

[15]  Sheng Xu,et al.  Clinical utility of real-time fusion guidance for biopsy and ablation. , 2011, Journal of vascular and interventional radiology : JVIR.

[16]  Baris Turkbey,et al.  Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? , 2011, Radiology.

[17]  K. Wallner,et al.  The Incidence of Transition Zone Prostate Cancer Diagnosed by Transperineal Template Guided Mapping Biopsy: Implications for Treatment Planning , 2010 .

[18]  C. Magi-Galluzzi,et al.  Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy. , 2010, Urology.

[19]  A. Evans,et al.  ‘Prostatic evasive anterior tumours’: the role of magnetic resonance imaging , 2010, BJU international.

[20]  K. Fareed,et al.  Importance of additional "extreme" anterior apical needle biopsies in the initial detection of prostate cancer. , 2010, Urology.

[21]  P. Choyke,et al.  Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. , 2010, Radiology.

[22]  D Andrew Loblaw,et al.  Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. , 2010, The Journal of urology.

[23]  Thomas Hambrock,et al.  Magnetic resonance imaging guided prostate biopsy in men with repeat negative biopsies and increased prostate specific antigen. , 2010, The Journal of urology.

[24]  K. Wallner,et al.  Performance of transperineal template-guided mapping biopsy in detecting prostate cancer in the initial and repeat biopsy setting , 2009, Prostate Cancer and Prostatic Diseases.

[25]  R. Mammadov,et al.  Is It Possible to Predict Sepsis, the Most Serious Complication in Prostate Biopsy? , 2009, Urologia Internationalis.

[26]  A. Morgentaler.  Testosterone therapy in men with prostate cancer: scientific and ethical considerations. , 2009, The Journal of urology.

[27]  C. Magi-Galluzzi,et al.  Prostate cancer volume at biopsy predicts clinically significant upgrading. , 2008, The Journal of urology.

[28]  P. Scardino,et al.  The clinical features of anterior prostate cancers , 2006, BJU international.

[29]  P. Nelson,et al.  Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. , 2006, JAMA.

[30]  A. Henderson,et al.  Extensive transperineal template biopsies of prostate: modified technique and results. , 2006, Urology.

[31]  P. Javlé,et al.  Importance of TURP in diagnosing prostate cancer in men with multiple negative biopsies , 2005, The Prostate.

[32]  N. Shinohara,et al.  Differences in tumor core distribution between palpable and nonpalpable prostate tumors in patients diagnosed using extensive transperineal ultrasound‐guided template prostate biopsy , 2005, Cancer.

[33]  S. Bott,et al.  Anterior prostate cancer: is it more difficult to diagnose? , 2002, BJU international.

[34]  D. Johnston,et al.  Detailed mapping of prostate carcinoma foci , 2000, Cancer.

[35]  A S Whittemore,et al.  Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.

[36]  Yipeng Hu,et al.  The PICTURE study -- prostate imaging (multi-parametric MRI and Prostate HistoScanning™) compared to transperineal ultrasound guided biopsy for significant prostate cancer risk evaluation. , 2014, Contemporary clinical trials.

[37]  Thomas Hambrock,et al.  Prospective assessment of prostate cancer aggressiveness using 3-T diffusion-weighted magnetic resonance imaging-guided biopsies versus a systematic 10-core transrectal ultrasound prostate biopsy cohort. , 2012, European urology.

[38]  Theodorus H van der Kwast,et al.  A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. , 2011, The Journal of urology.

[39]  P. Scardino,et al.  Anatomy of the prostate and distribution of early prostate cancer. , 1995, Seminars in surgical oncology.